Katherine Warren is an Oncology physician affiliated with Harvard University. OpenAlex indexes 214 publications with 8,655 citations (h-index 47); ClinicalTrials.gov lists 10 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
450 Brookline Ave
Boston, MA 02215
Telephone
617-632-3000Registry record last updated 5 Nov 2019.
Clinical trials
- Phase I Study of Marizomib + Panobinostat for Children With DIPG
Sponsor: Dana-Farber Cancer Institute
- Low-Dose or High-Dose Lenalidomide in Treating Younger Patients With Recurrent, Refractory, or Progressive Pilocytic Astrocytoma or Optic Pathway Glioma
Sponsor: National Cancer Institute (NCI)
- AZD8055 for Adults With Recurrent Gliomas
Sponsor: National Cancer Institute (NCI)
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- GlaxoSmithKline, LLC.Program year20231 payment
- Y-mAbs Therapeutics, Inc.Program year20211 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
1 NIH research award on record, funded 2021–2023 per NIH RePORTER. The latest:
- Opioid Prescribing and Chronic Pain in the Primary Care Setting
Harvard Medical School
FY2023$50,670F30DA052116 - Opioid Prescribing and Chronic Pain in the Primary Care Setting
Harvard Medical School
FY2022$54,252F30DA052116 - Opioid Prescribing and Chronic Pain in the Primary Care Setting
Harvard Medical School
FY2021$40,559F30DA052116
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Vaccine Side Effects Following COVID-19 Vaccination Among the Residents of the UAE—An Observational Study
Frontiers in Public Health
2022 - Joint EANM/SIOPE/RAPNO practice guidelines/SNMMI procedure standards for imaging of paediatric gliomas using PET with radiolabelled amino acids and [18F]FDG: version 1.0
European Journal of Nuclear Medicine and Molecular Imaging
2022
Similar KOLs
Other experts from the same institution or the same specialty.
Felipe Fregni, MD, MPH
Harvard University
Joseph Antin, MD
Harvard University
Sarah Fortune, MD
Harvard University
Elizabeth Buchbinder, MD
Harvard University
Carl June, MD
University of Pennsylvania
Rainer Storb
University of Washington
Christina Fitzmaurice, MD
Larry Norton, MD
Memorial Sloan Kettering Cancer Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”